MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202421021561 A) filed by Alkem Laboratories Limited, Maharashtra, on March 21, 2024, for 'pharmaceutical composition comprising deutetrabenazine.'
Inventor(s) include Ashish Sehgal; Satyanarayana Tallam; Roshan Sandal; Sagar Jugalkishor Baheti; and Prafulla Chandrakant Firodiya.
The application for the patent was published on Sept. 26, under issue no. 39/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to compositions of Deutetrabenazine having enhanced bioavailability, more specifically stable extended release compositions comprising Deutetrabenazine and pharmaceutically acceptable excipients and method of manufacturing thereof. The invention also relates to the use of said stable composition for the treatment of hyperkinetic movement disorders deriving from conditions such as Huntington's disease, tardive dyskinesia, Tourette syndrome, levodopa-induced dyskinesia and dyskinesia in cerebral palsy."
Disclaimer: Curated by HT Syndication.
